US Stock MarketDetailed Quotes
COGT Cogent Biosciences
- 9.115
- +0.035+0.39%
Trading Nov 21 14:33 ET
1.01BMarket Cap-3675P/E (TTM)
9.270High9.010Low376.65KVolume9.120Open9.080Pre Close3.45MTurnover0.59%Turnover RatioLossP/E (Static)110.46MShares12.61052wk High4.94P/B585.23MFloat Cap3.67052wk Low--Dividend TTM64.21MShs Float174.200Historical High--Div YieldTTM2.86%Amplitude1.904Historical Low9.153Avg Price1Lot Size
About Cogent Biosciences Company
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
Company Profile
SymbolCOGT
Company NameCogent Biosciences
Listing DateMar 29, 2018
Issue Price12.00
Founded2014
CEOMr. Andrews R. Robbins, M.B.A.
MarketNASDAQ
Employees164
Fiscal Year Ends12-31
Address275 Wyman Street,3rd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-945-5576
Websitehttp://www.cogentbio.com
Company Executives
- Name
- Position
- Salary
- Andrews R. Robbins, M.B.A.
- Director, Chief Executive Officer and President
- 7.90M
- Dr. Jessica Sachs, PhD
- Chief Medical Officer
- 3.00M
- Dr. John Edward Robinson, PhD
- Chief Scientific Officer
- 2.98M
- Evan Kearns
- Chief Legal Officer and Corporate Secretary
- --
- John Green
- Chief Financial Officer and Principal Accounting Officer
- --
- Peter Harwin
- Chairman of the Board
- 364.55K
- Dr. Chris Cain, PhD
- Independent Director
- 341.36K
- Matthew E. Ros
- Independent Director
- 336.69K
- Arlene M. Morris
- Independent Director
- 345.49K
- Dr. Karen Jean Ferrante, M.D.
- Independent Director
- 340.37K
- Todd E. Shegog
- Independent Director
- 345.80K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data